Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
Titel:
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
Auteur:
Falchook, Gerald S Lewis, Karl D Infante, Jeffrey R Gordon, Michael S Vogelzang, Nicholas J DeMarini, Douglas J Sun, Peng Moy, Christopher Szabo, Stephen A Roadcap, Lori T Peddareddigari, Vijay GR Lebowitz, Peter F Le, Ngocdiep T Burris III, Howard A Messersmith, Wells A O'Dwyer, Peter J Kim, Kevin B Flaherty, Keith Bendell, Johanna C Gonzalez, Rene Kurzrock, Razelle Fecher, Leslie A